Last checked at 2 Mar 2021 15:51
FORM 8.3 Amendment to purchase and sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | WILLIS TOWERS WATSON PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 26 FEB 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,938,309 | 1.50% | 383,139 | 0.30% | ||
(2) | Derivatives (other than options): | ||||
153,127 | 0.12% | 128,011 | 0.10% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
(4) | TOTAL: | ||||
2,097,536 | 1.63% | 517,250 | 0.40% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 221.6900 USD |
| Purchase | 3 | 222.2566 USD |
| Purchase | 13 | 223.1100 USD |
| Purchase | 41 | 220.4800 USD |
| Purchase | 42 | 222.7614 USD |
| Purchase | 77 | 221.4400 USD |
| Purchase | 100 | 220.6500 USD |
| Purchase | 100 | 220.6650 USD |
| Purchase | 192 | 221.3969 USD |
| Purchase | 226 | 221.0172 USD |
| Purchase | 400 | 220.9900 USD |
| Purchase | 648 | 221.7289 USD |
| Purchase | 842 | 221.6935 USD |
| Purchase | 1,550 | 221.8000 USD |
| Purchase | 1,877 | 220.7890 USD |
| Purchase | 2,213 | 222.5632 USD |
| Purchase | 2,593 | 221.9873 USD |
| Purchase | 5,200 | 221.0408 USD |
| Purchase | 9,164 | 221.8219 USD |
| Purchase | 19,367 | 220.9557 USD |
| Purchase | 47,450 | 221.7884 USD |
| Purchase | 61,424 | 220.6400 USD |
| Sale | 1 | 221.1800 USD |
| Sale | 62 | 223.2300 USD |
| Sale | 100 | 222.4100 USD |
| Sale | 100 | 221.1100 USD |
| Sale | 150 | 222.4133 USD |
| Sale | 153 | 221.8666 USD |
| Sale | 200 | 220.6500 USD |
| Sale | 204 | 221.1690 USD |
| Sale | 261 | 221.1083 USD |
| Sale | 340 | 220.9711 USD |
| Sale | 379 | 221.2032 USD |
| Sale | 400 | 220.9900 USD |
| Sale | 465 | 222.2131 USD |
| Sale | 546 | 220.6905 USD |
| Sale | 557 | 222.2544 USD |
| Sale | 634 | 222.3405 USD |
| Sale | 719 | 221.0289 USD |
| Sale | 770 | 221.8771 USD |
| Sale | 1,000 | 222.5260 USD |
| Sale | 1,358 | 221.1833 USD |
| Sale | 1,379 | 221.9115 USD |
| Sale | 1,425 | 221.0229 USD |
| Sale | 1,468 | 221.7392 USD |
| Sale | 1,516 | 222.2212 USD |
| Sale | 1,577 | 221.5114 USD |
| Sale | 1,650 | 221.7312 USD |
| Sale | 1,748 | 222.6563 USD |
| Sale | 1,824 | 222.3252 USD |
| Sale | 1,845 | 222.0037 USD |
| Sale | 2,143 | 221.4159 USD |
| Sale | 2,802 | 222.0935 USD |
| Sale | 5,816 | 221.7973 USD |
| Sale | 6,409 | 221.8996 USD |
| Sale | 8,180 | 221.7130 USD |
| Sale | 11,457 | 221.4196 USD |
| Sale | 12,199 | 221.8376 USD |
| Sale | 12,672 | 220.6403 USD |
| Sale | 19,919 | 220.9444 USD |
| Sale | 49,074 | 220.6400 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure | 2 March 2021 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
| Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005852/en/
Copyright Business Wire 2021